StockData
Alkermes plc. logo

Alkermes plc. (ALKS) stock

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30208% above fair value
$45.45−1.08 (-2.32%)

Close on Nov 17, 2026Market cap $7.62BP/E 119.6Yield –

Alkermes pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Alkermes's pe ratio was 126.0× on Nov 11, 2026, against 14.6× a year earlier. Over the last 5 years it ranged from 9.2× to 441.0×, with a median of 42.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026126.0×+112.2
2025Dec 31, 202513.9×−0.7
2024Dec 31, 202414.6×−7.8
2023Dec 29, 202322.4×−155.5
2016Jan 29, 2016177.8×−263.2
2015Dec 31, 2015441.0×+115.7
2014Dec 31, 2014325.3×+99.4
2013Dec 31, 2013225.9×–

More Alkermes figures

See a number that looks wrong?